2005
DOI: 10.1002/ardp.200400930
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Some Pyrazoloquinolines as Inhibitors of Herpes Simplex Virus Type 1 Replication

Abstract: Three structurally related aminopyrazoloquinoline derivatives were evaluated for their antiviral activity against Herpes Simplex virus type 1. These compounds were examined for their in vitro antiviral activity by two different bioassays, namely; crystal violet staining and tetrazolium dye (MTS) measurement. The antiviral role of these compounds was confirmed by enumerating the infectious particles with plaque assay. The acute toxicity values of the biologically active compounds were determined prior to their … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
11
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 34 publications
0
11
0
Order By: Relevance
“…Keeping this in mind, we synthesized several pharmacologically active aminopyrazoloquinoline derivatives with and without sugar moieties, which have been shown to possess different degree of antiviral activities against HSV-type 1 (HSV-1) (1, 2). The 3-amino-7-methoxy-1H-pyrazolo [3, 4-b] quinoline (compound 3, Fig.…”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“…Keeping this in mind, we synthesized several pharmacologically active aminopyrazoloquinoline derivatives with and without sugar moieties, which have been shown to possess different degree of antiviral activities against HSV-type 1 (HSV-1) (1, 2). The 3-amino-7-methoxy-1H-pyrazolo [3, 4-b] quinoline (compound 3, Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Acyclovir had been the drug of choice for several decades; however, the emergence of acyclovir-resistant Herpes Simplex Virus (HSV) isolate in the immunocompromised patients and organ or bone marrow recipients has led to the discovery of new antiviral compounds ( 3 - 5 , 9 , 10 ). Keeping this in mind, we synthesized several pharmacologically active aminopyrazoloquinoline derivatives with and without sugar moieties, which have been shown to possess different degree of antiviral activities against HSV-type 1 (HSV-1) ( 1 , 2 ). The 3-amino-7-methoxy-1H-pyrazolo [3, 4-b] quinoline (compound 3, Fig.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations